Martin Lauss
Martin Lauss
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,#,
Marco Donia
Marco Donia
2Center for Cancer Immune Therapy, Department of Hematology, Herlev Ringvej 75, 2730 Herlev, Denmark
3Department of Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, 2730 Herlev, Denmark
2,3,#,
Katja Harbst
Katja Harbst
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,#,
Rikke Andersen
Rikke Andersen
2Center for Cancer Immune Therapy, Department of Hematology, Herlev Ringvej 75, 2730 Herlev, Denmark
3Department of Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, 2730 Herlev, Denmark
2,3,
Shamik Mitra
Shamik Mitra
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Frida Rosengren
Frida Rosengren
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Maryem Salim
Maryem Salim
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Johan Vallon-Christersson
Johan Vallon-Christersson
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Therese Törngren
Therese Törngren
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Anders Kvist
Anders Kvist
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,
Markus Ringnér
Markus Ringnér
4Department of Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Sölvegatan 35, 22362 Lund, Sweden
4,
Inge Marie Svane
Inge Marie Svane
2Center for Cancer Immune Therapy, Department of Hematology, Herlev Ringvej 75, 2730 Herlev, Denmark
3Department of Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, 2730 Herlev, Denmark
2,3,#,
Göran Jönsson
Göran Jönsson
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
1,✉,#
1Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Scheelegatan 2, Medicon Village, 22185 Lund, Sweden
2Center for Cancer Immune Therapy, Department of Hematology, Herlev Ringvej 75, 2730 Herlev, Denmark
3Department of Oncology, Copenhagen University Hospital Herlev, Herlev Ringvej 75, 2730 Herlev, Denmark
4Department of Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Lund University, Sölvegatan 35, 22362 Lund, Sweden
Subject terms: Melanoma, Tumour immunology
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.